Premium
‘Chimeric’ Grafts Assembled from Multiple Allodisparate Donors Enjoy Enhanced Transplant Survival
Author(s) -
Saban D. R.,
Chauhan S. K.,
Zhang X.,
El Annan J.,
Jin Y.,
Dana R.
Publication year - 2009
Publication title -
american journal of transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.89
H-Index - 188
eISSN - 1600-6143
pISSN - 1600-6135
DOI - 10.1111/j.1600-6143.2008.02535.x
Subject(s) - alloimmunity , epithelium , corneal epithelium , medicine , transplantation , chimera (genetics) , corneal transplantation , immunology , endothelium , cornea , pathology , biology , surgery , ophthalmology , biochemistry , gene
Certain components of a graft that provoke alloimmunity may not be vital for graft function or critical as targets of rejection. Corneal transplantation is an example of this, because graft epithelium plays a role in allosensitization, whereas corneal graft endothelium—which shares the same alloantigens—is the critical target in allorejection. In this study, we found that exploiting this biology by replacing donor epithelium of an allograft with an allodisparate third‐party epithelium yields a marked enhancement in transplant survival. Such ‘chimeric’ allografts consisted of a C3H/He (H‐2 k ) corneal epithelium over a C57BL/6 (H‐2 b ) epithelial‐denuded cornea (or v.v. ) and orthotopically placed on BALB/c (H‐2 d ) hosts. Conventional corneal allografts (C3H/He or C57BL/6) or isografts (BALB/c) were also transplanted on BALB/c hosts. Alloreactive T‐cell frequencies (CD4 + interferon [IFN]‐γ + ) primed to the graft endothelium were strongly diminished in chimeric hosts relative to conventionally allografted hosts. This was corroborated by a decreased T‐cell infiltration (p = 0.03) and a marked enhancement of allograft survival (p = 0.001). Our results represent the first successful demonstration of chimeric tissue, epithelial‐denuded allograft plus third‐party allodisparate epithelium, in the promotion of allograft survival. Moreover, chimeric grafting can be readily performed clinically, whereby corneal allograft rejection remains a significant problem particularly in inflamed graft beds.